CONTENTSIssue 90 | January 2020In association within the pinkTracking the evolution of breast cancer treatment over the past three decadesPrep in the ukIs NHS England failing patients by restricting access to PrEP medication?debate: taxationTaxing Big Pharma has become a key talking point in the 2020 US presidential racein the pipelineEndometriosis is gaining more attention, but what treatments are available?Fake drugsCounterfeit medication has become a serious problem for patient and providers in Africaoff the shelfCreating off-the-shelf versions of precision medicines could help manufacturersa nobel discoveryUnderstanding the relationship between cells and oxygen could fuel drug discovery Charming chinaBig Pharma is pulling out all the stops to gain access to the lucrative Chinese marketoutsourcingTips for a joined-up approach to Regulatory and PV outsourcingnext generationPharmacovigilance 2.0: reskilling for the digital & data science age02/24/2024 01:30:56